Real-time enrollment status for this juvenile myelomonocytic leukemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:56 AM UTC
| NCT Number | NCT05849662 |
| Recruiting Status | Recruiting |
| Condition | Juvenile Myelomonocytic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 58 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Therapeutic Advances in Childhood Leukemia Consortium |
| Last Updated on CT.gov | September 4, 2026 (Sep 4, 2026) |
As of October 16, 2026: Clinical trial NCT05849662 is currently recruiting participants. This phase1 study for juvenile myelomonocytic leukemia is actively seeking new participants at 21 locations across the United States. The study is sponsored by Therapeutic Advances in Childhood Leukemia Consortium. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05849662 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05849662 was last updated Sep 4, 2026 (September 4, 2026). HelloStudys verifies this status automatically.